Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide

INTRODUCTION: While the liraglutide effect and action in diabetes (LEAD-6) clinical trial compared the efficacy and safety of liraglutide once daily (LIRA) to exenatide twice daily (EXEN) in adult patients with type 2 diabetes, few studies have explored the associated per-patient costs of glycemic g...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: DeKoven, Mitch, Lee, Won Chan, Bouchard, Jonathan, Massoudi, Marjan, Langer, Jakob
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2014
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930836/
https://ncbi.nlm.nih.gov/pubmed/24477354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-014-0098-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller